SBIR Phase I: Use of Phase-Transition Biopolymers as Novel Enzyme Carriers for Biocatalysis
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2003Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- PhaseBio Pharmaceuticals Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MLJSHGTEWU43
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
- Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
- Smart DeltaPhase Tags for Purification of Recombinant Peptides
- Low Cost Production of Recombinant Proteins
- Biopolymers for Relevant Recombinant Protein Puification
Research funding history
6 SBIR/STTR records share this UEI (2003–2018). Reported award amounts total $3,687,390. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation